186 related articles for article (PubMed ID: 25355596)
1. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.
Liu W; De La Torre IG; Gutiérrez-Rivera MC; Wang B; Liu Y; Dai L; Qian W; Zhang JY
Tumour Biol; 2015 Feb; 36(2):1307-12. PubMed ID: 25355596
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J
Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877
[TBL] [Abstract][Full Text] [Related]
3. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
[TBL] [Abstract][Full Text] [Related]
4. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.
Ye H; Sun C; Ren P; Dai L; Peng B; Wang K; Qian W; Zhang J
Oncol Lett; 2013 Feb; 5(2):663-668. PubMed ID: 23420714
[TBL] [Abstract][Full Text] [Related]
5. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.
Wang P; Song C; Xie W; Ye H; Wang K; Dai L; Zhang Y; Zhang J
J Immunol Res; 2014; 2014():512540. PubMed ID: 24822225
[TBL] [Abstract][Full Text] [Related]
8. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a panel of tumor-associated antigens in breast cancer.
Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C
Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604
[TBL] [Abstract][Full Text] [Related]
10. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
[TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
[TBL] [Abstract][Full Text] [Related]
13. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
[TBL] [Abstract][Full Text] [Related]
14. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens.
Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY
J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
16. Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.
Li L; Wang K; Dai L; Wang P; Peng XX; Zhang JY
Mol Med Rep; 2008; 1(4):589-94. PubMed ID: 20523766
[TBL] [Abstract][Full Text] [Related]
17. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
[TBL] [Abstract][Full Text] [Related]
18. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.
Qin J; Wang S; Shi J; Ma Y; Wang K; Ye H; Zhang X; Wang P; Wang X; Song C; Dai L; Wang K; Jiang B; Zhang J
Cancer Sci; 2019 Jun; 110(6):1829-1841. PubMed ID: 30950146
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of an immunodiagnostic model for prediction of breast cancer.
Qiu C; Wang P; Wang B; Shi J; Wang X; Li T; Qin J; Dai L; Ye H; Zhang J
Oncoimmunology; 2020; 9(1):1682382. PubMed ID: 32002291
[TBL] [Abstract][Full Text] [Related]
20. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
Looi K; Megliorino R; Shi FD; Peng XX; Chen Y; Zhang JY
Oncol Rep; 2006 Nov; 16(5):1105-10. PubMed ID: 17016600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
